The value of delayed phase enhanced imaging in malignant pleural mesothelioma.

about

Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.

P2860

Q51731968-23A78F3A-E5C6-4D94-A06E-E9108E035F88

P2860

The value of delayed phase enhanced imaging in malignant pleural mesothelioma.

Item

http://www.wikidata.org/entity/Q41307384

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The value of delayed phase enhanced imaging in malignant pleural mesothelioma.

@en

type

Item

label

The value of delayed phase enhanced imaging in malignant pleural mesothelioma.

@en

prefLabel

The value of delayed phase enhanced imaging in malignant pleural mesothelioma.

@en

P1476

The value of delayed phase enhanced imaging in malignant pleural mesothelioma.

@en

P2093

Akash M Patel

http://www.w3.org/2001/XMLSchema#string

Andrew R Haas

http://www.w3.org/2001/XMLSchema#string

Arun C Nachiappan

http://www.w3.org/2001/XMLSchema#string

Drew A Torigian

http://www.w3.org/2001/XMLSchema#string

E Paul Wileyto

http://www.w3.org/2001/XMLSchema#string

Eduardo M Barbosa

http://www.w3.org/2001/XMLSchema#string

Evan W Alley

http://www.w3.org/2001/XMLSchema#string

Ian Berger

http://www.w3.org/2001/XMLSchema#string

Keith A Cengel

http://www.w3.org/2001/XMLSchema#string

Maya Galperin-Aizenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Diffusion magnetic resonance imaging of chest tumors.

Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.

Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.

A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria.

Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.

Initial analysis of the international association for the study of lung cancer mesothelioma database.

Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma.

Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes.

P304

2344-2349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2017.07.86

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sharyn Katz

Charles B Simone

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28932538

http://www.w3.org/2001/XMLSchema#string

P932

5594138

http://www.w3.org/2001/XMLSchema#string

The value of delayed phase enhanced imaging in malignant pleural mesothelioma.

about

P2860

P2860

The value of delayed phase enhanced imaging in malignant pleural mesothelioma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932